Matloob Ahmad

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 24

Top Topics

Molecular Docking

Anti Inflammatory

Respiratory Syndrome Coronavirus

Carbon Nanotubes

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Muhammad Shahid Nazir, Matloob Ahmad, Sana Aslam, Ayesha Rafiq, Magdi E A Zaki, Magdi E A Zaki
A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds. Drug design, development and therapy 18 (2024)
Muhammad Shahid Nazir, Matloob Ahmad, Sana Aslam, Ayesha Rafiq, Magdi E A Zaki, Magdi E A Zaki
A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds. Drug design, development and therapy 18 (2024)
Muhammad Shahid Nazir, Matloob Ahmad, Sana Aslam, Ayesha Rafiq, Magdi E A Zaki, Magdi E A Zaki
A Comprehensive Update of Anti-COVID-19 Activity of Heterocyclic Compounds. Drug design, development and therapy 18 (2024)
Ayesha Rafiq, Tooba Jabeen, Sana Aslam, Matloob Ahmad, Usman Ali Ashfaq, Noor Ul Amin Mohsin, Magdi E A Zaki, Sami A Al-Hussain
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products. Molecules (Basel, Switzerland) 28 (12) (2023)
Ayesha Rafiq, Tooba Jabeen, Sana Aslam, Matloob Ahmad, Usman Ali Ashfaq, Noor Ul Amin Mohsin, Magdi E A Zaki, Sami A Al-Hussain
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products. Molecules (Basel, Switzerland) 28 (12) (2023)
Aysha Arshad Rana, Amnah Yusaf, Salma Shahid, Muhammad Usman, Matloob Ahmad, Sana Aslam, Sami A Al-Hussain, Magdi E A Zaki
Unveiling the Role of Nonionic Surfactants in Enhancing Cefotaxime Drug Solubility: A UV-Visible Spectroscopic Investigation in Single and Mixed Micellar Formulations. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Aysha Arshad Rana, Amnah Yusaf, Salma Shahid, Muhammad Usman, Matloob Ahmad, Sana Aslam, Sami A Al-Hussain, Magdi E A Zaki
Unveiling the Role of Nonionic Surfactants in Enhancing Cefotaxime Drug Solubility: A UV-Visible Spectroscopic Investigation in Single and Mixed Micellar Formulations. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Ayesha Rafiq, Tooba Jabeen, Sana Aslam, Matloob Ahmad, Usman Ali Ashfaq, Noor Ul Amin Mohsin, Magdi E A Zaki, Sami A Al-Hussain
A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products. Molecules (Basel, Switzerland) 28 (12) (2023)
Amnah Yusaf, Muhammad Usman, Matloob Ahmad, Muhammad Sadiq, Asim Mansha, Sami A Al-Hussain, Magdi E A Zaki, Hafiza Fatima Rehman
Highly Selective Methodology for Entrapment and Subsequent Removal of Cobalt (II) Ions under Optimized Conditions by Micellar-Enhanced Ultrafiltration. Molecules (Basel, Switzerland) 27 (23) (2022)
Samman Munir, Mohsin Khurshid, Matloob Ahmad, Usman Ali Ashfaq, Magdi E A Zaki
Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of E. coli DNA Gyrase: An In Vitro and In Silico Study. Pharmaceutics 14 (12) (2022)
Samman Munir, Mohsin Khurshid, Matloob Ahmad, Usman Ali Ashfaq, Magdi E A Zaki
Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of E. coli DNA Gyrase: An In Vitro and In Silico Study. Pharmaceutics 14 (12) (2022)
Imran Ahmad Khan, Furqan Ahmad Saddique, Sana Aslam, Usman Ali Ashfaq, Matloob Ahmad, Sami A Al-Hussain, Magdi E A Zaki
Synthesis of Novel N -Methylmorpholine-Substituted Benzimidazolium Salts as Potential α-Glucosidase Inhibitors. Molecules (Basel, Switzerland) 27 (18) (2022)
Amnah Yusaf, Muhammad Usman, Matloob Ahmad, Muhammad Sadiq, Asim Mansha, Sami A Al-Hussain, Magdi E A Zaki, Hafiza Fatima Rehman
Highly Selective Methodology for Entrapment and Subsequent Removal of Cobalt (II) Ions under Optimized Conditions by Micellar-Enhanced Ultrafiltration. Molecules (Basel, Switzerland) 27 (23) (2022)
Amnah Yusaf, Muhammad Usman, Matloob Ahmad, Muhammad Sadiq, Asim Mansha, Sami A Al-Hussain, Magdi E A Zaki, Hafiza Fatima Rehman
Highly Selective Methodology for Entrapment and Subsequent Removal of Cobalt (II) Ions under Optimized Conditions by Micellar-Enhanced Ultrafiltration. Molecules (Basel, Switzerland) 27 (23) (2022)
Noor Ul Amin Mohsin, Sana Aslam, Matloob Ahmad, Muhammad Irfan, Sami A Al-Hussain, Magdi E A Zaki
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Furqan Ahmad Saddique, Matloob Ahmad, Usman Ali Ashfaq, Muhammad Muddassar, Sadia Sultan, Magdi E A Zaki
Identification of Cyclic Sulfonamides with an N- Arylacetamide Group as α-Glucosidase and α-Amylase Inhibitors: Biological Evaluation and Molecular Modeling. Pharmaceuticals (Basel, Switzerland) 15 (1) (2022)
Amnah Yusaf, Muhammad Usman, Matloob Ahmad, Muhammad Sadiq, Asim Mansha, Sami A Al-Hussain, Magdi E A Zaki, Hafiza Fatima Rehman
Highly Selective Methodology for Entrapment and Subsequent Removal of Cobalt (II) Ions under Optimized Conditions by Micellar-Enhanced Ultrafiltration. Molecules (Basel, Switzerland) 27 (23) (2022)
Samman Munir, Mohsin Khurshid, Matloob Ahmad, Usman Ali Ashfaq, Magdi E A Zaki
Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of E. coli DNA Gyrase: An In Vitro and In Silico Study. Pharmaceutics 14 (12) (2022)
Noor Ul Amin Mohsin, Sana Aslam, Matloob Ahmad, Muhammad Irfan, Sami A Al-Hussain, Magdi E A Zaki
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Noor Ul Amin Mohsin, Sana Aslam, Matloob Ahmad, Muhammad Irfan, Sami A Al-Hussain, Magdi E A Zaki
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Samman Munir, Mohsin Khurshid, Matloob Ahmad, Usman Ali Ashfaq, Magdi E A Zaki
Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of E. coli DNA Gyrase: An In Vitro and In Silico Study. Pharmaceutics 14 (12) (2022)
Noor Ul Amin Mohsin, Sana Aslam, Matloob Ahmad, Muhammad Irfan, Sami A Al-Hussain, Magdi E A Zaki
Cyclooxygenase-2 (COX-2) as a Target of Anticancer Agents: A Review of Novel Synthesized Scaffolds Having Anticancer and COX-2 Inhibitory Potentialities. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Imran Ahmad Khan, Matloob Ahmad, Usman Ali Ashfaq, Sadia Sultan, Magdi E A Zaki
Discovery of Amide-Functionalized Benzimidazolium Salts as Potent α-Glucosidase Inhibitors. Molecules (Basel, Switzerland) 26 (16) (2021)
Furqan Ahmad Saddique, Sana Aslam, Matloob Ahmad, Usman Ali Ashfaq, Muhammad Muddassar, Sadia Sultan, Saman Taj, Muzammil Hussain, Dae Sung Lee, Magdi E A Zaki
Synthesis and α-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl]-N-arylacetamides: An In Silico and Biochemical Approach. Molecules (Basel, Switzerland) 26 (10) (2021)